Marshall Fordyce, President and CEO at Vera Therapeutics, Inc. (VERA), sold 10,420 shares at $16.66 ($174K) on 2023-08-21, disclosed to the SEC on 2023-08-23.
Scheduled sale ($174k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.66 | 5,210 | $87K | 50.0% |
| 2 | $16.66 | 5,210 | $87K | 50.0% |
| Total | $16.66 avg | 10,420 | $174K | 100% |
| Filing → |
| VERA | SELL | 2026-07-09 | $2.0M | — | Filing → |
| VERA | SELL | 2026-06-24 | $702K | — | Filing → |
| VERA | SELL | 2026-05-13 | $680K | — | Filing → |